Re: Enhancement of tumor response to gamma-radiation by an inhibitor of cyclooxygenase-2 enzyme.
Gallo
O
O
D017209:Apoptosis / Q000187:drug effects; D017024:Chemotherapy, Adjuvant; D051546:Cyclooxygenase 2; D052246:Cyclooxygenase 2 Inhibitors; D016861:Cyclooxygenase Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use; D016228:Endothelial Growth Factors / Q000494:pharmacology*; D005720:Gamma Rays; D006801:Humans; D007527:Isoenzymes / Q000494:pharmacology*; D008222:Lymphokines / Q000494:pharmacology*; D008565:Membrane Proteins; D009369:Neoplasms / Q000098:blood supply / Q000188:drug therapy* / Q000532:radiotherapy*; D009389:Neovascularization, Pathologic / Q000378:metabolism / Q000517:prevention & control*; D011451:Prostaglandin-Endoperoxide Synthases / Q000494:pharmacology*; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
D052246:Cyclooxygenase 2 Inhibitors; D016861:Cyclooxygenase Inhibitors; D016228:Endothelial Growth Factors; D007527:Isoenzymes; D008222:Lymphokines; D008565:Membrane Proteins; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; D051546:Cyclooxygenase 2; C496540:PTGS2 protein, human; D011451:Prostaglandin-Endoperoxide Synthases